An interventional study of DREAMS-OT in Delirium, Postoperative, sponsored by National University Hospital, Singapore. Recruiting at 1 site in Singapore. Open to participants aged 21 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-03-30.
Sponsored by National University Hospital, Singapore · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Emergence Delirium with a site in Singapore — 3 open to participants now, 3 under way, none of them phase 3. Emergence Delirium · Singapore.
Among the 10 studies in Emergence Delirium with a site in Singapore, this one is the only one that started in 2024, is one of 4 with no phase, and was the 8th registered.
753 studies on the registry are indexed under Emergence Delirium; 261 are open to participants now.
Browse Emergence Delirium studies →3 of the 10 studies in Emergence Delirium with a site in Singapore are open now. Recruiting first, the newest first:
Sengkang General Hospital · Sites in Singapore
Ages 60+ · Healthy volunteers
National University Hospital, Singapore · Sites in Singapore
Ages 65–100
A study can be open while its sites in Singapore have not opened yet or have stopped. Only those recruiting at a site in Singapore →
Of the 141 Emergence Delirium studies recruiting now, 78 (55%) set no upper age limit and 43 (30%) stop at 75 or younger; 33 take children under 18; 24 take healthy volunteers.
This study: 21 Years to 99 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2014; this study’s year is marked. 1 started in 2024.
This study's planned enrollment of 300 is above the median of 120 across 467 interventional studies indexed under Emergence Delirium.
Median enrollment 125 across the 4 interventional studies, 325 across the 6 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 10 has an industry lead sponsor. The 4 most frequent:
National University Hospital, Singapore is the lead sponsor of 455 studies on the registry; 100 are open to participants now.
National University Hospital, Singapore has 5 studies filed under Emergence Delirium — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 10 studies in Emergence Delirium with a site in Singapore, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The goal of this randomized-controlled trial (RCT) is to compare the effectiveness of the DREAMS-OT intervention with standard care in reducing post-Coronary Artery Bypass Graft (CABG) surgery delirium in patients undergoing CABG surgery.
The aims of the study are:
The study team will compare intervention group and standard care group (control group) to see if there is a reduction in the incidence of delirium in patients 5 days post-CABG.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients will receive an early and intensive occupational therapy protocol starting within the first 15 hours after extubation.
Other: DREAMS-OT
Standard care OT as per current ICU setting
Patients will receive the DREAMS-OT protocol 3 times per day, 20 minutes per therapy session. Intervention frequency will be confirmed with a feasibility trial. If not feasible to maintain 3 times per day, the intervention will still be maintained at the same intensity of 1 hour per day, with a graded approach.
Delirium
Incidence of delirium from Day 1 to Day 5 post-CABG are measured using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) assessment tool.
Time frame: Day 1 of post-CABG (AM and PM), Day 2 of post-CABG (AM and PM), Day 3 of post-CABG (AM and PM), Day 4 of post-CABG (AM and PM), Day 5 of post-CABG (AM and PM); (+/- 1 day for last measurement)
Delirium
Incidence of delirium from Day 1 to Day 5 post-CABG are measured using the 3-Minute Diagnostic Interview for Confusion Assessment Method (3D-CAM).
Time frame: Day 1 of post-CABG (AM and PM), Day 2 of post-CABG (AM and PM), Day 3 of post-CABG (AM and PM), Day 4 of post-CABG (AM and PM), Day 5 of post-CABG (AM and PM); (+/- 1 day for last measurement)
Length of Stay
Length of stay in ICU and hospital in days
Time frame: 3-months post-CABG (+/- 1 month)
Duration of Delirium
Duration of delirium in subgroup of participants who develop delirium
Time frame: Day 1 of post-CABG (AM and PM), Day 2 of post-CABG (AM and PM), Day 3 of post-CABG (AM and PM), Day 4 of post-CABG (AM and PM), Day 5 of post-CABG (AM and PM)
Sleep Quality
Sleep quality (Duration of Total Sleep, Light Sleep, Deep Sleep and Rapid Eye Movement (REM) Sleep in hours) as measured with Oura Ring, a wearable sleep tracking device
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks), Day 1 of post-CABG, Day 2 of post-CABG (+/- 1 day), 3 months post-CABG for 3 consecutive days (+/- 1 month)
Functional Status
Functional status measured using Acute Care Index of Function (ACIF). The score ranges from 0 - 176 (or 206 for wheelchair-bound participants), with higher scores indicating better functional performance.
Time frame: Day 5 of post-CABG (+/- 1 day)
Physical Status
Physical status measured using Functional Independence Measure (FIM). The score ranges from 0 - 126, with higher scores indicating better physical status.
Time frame: Day 5 of post-CABG (+/- 1 day), 3 months post-CABG (+/- 1 month)
Cognitive status
Cognitive status measurement using Montreal Cognitive Assessment (MoCA). The score ranges from 0 - 30, with higher scores indicating better cognitive status.
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks), Day 5 of post-CABG (+/- 1 day), 3 months post-CABG (+/- 1 month)
Psychological State
Psychological state measured using the Hospital Anxiety and Depression Scale (HADS). The score ranges from 0 - 21, with higher scores indicating worse psychological state.
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks), Day 5 of post-CABG (+/-1 day), 3 months post-CABG (+/- 1 month)
Cognitive status
Cognitive status measured using the Weekly Calendar Planning Activity (WCPA) is assessed using an efficiency score derived from accuracy and time to completion. Higher scores indicate better performance. The score is a continuous variable without a fixed range.
Time frame: 3-months post-CABG (+/- 1 month)
Richmond Agitation Sedation Scale (RASS)
RASS which will be used for CAM-ICU assessment (primary outcome measure). The scores range from -5 to +4, with higher score indicating greater agitation and lower scores indicating deeper sedation.
Time frame: Day 1 of post-CABG (AM and PM), Day 2 of post-CABG (AM and PM), Day 3 of post-CABG (AM and PM), Day 4 of post-CABG (AM and PM), Day 5 of post-CABG (AM and PM)
European System for Cardiac Operative Risk Evaluation (EuroSCORE) 2
EuroSCORE 2 is used to assess the risk of heart surgery of participants before their CABG surgery. The score ranges from 0% - 100%, with higher percentage indicating worse outcome or greater predicted mortality risk.
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks)
Charlson Comorbidity Index (CCI)
Predicts mortality for participant before CABG surgery. The score ranges from 0 - 37, with higher score indicating worse outcome or greater comorbidity burden and mortality risk.
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks)
Clinical Frailty Index (CFI)
Measure health status of participant before surgery. The score range from 0 - 9, with higher score indicating worse outcome.
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks)
ICU Mobility Score
Assesses the highest level of mobility achieved in the ICU. The score range from 0 - 10, with higher score indicating better ouctome or greater mobility.
Time frame: Day 1, Day 2 and Day 3 of post-CABG (+/- 1 day, or until day of ICU discharge)
Pain Score
Measure pain score of participant. The score range from 0 - 10, with higher score indicating worse outcome or greater pain intensity.
Time frame: Day 1 of post-CABG, Day 2 of post-CABG, Day 3 of post-CABG, Day 4 of post-CABG, Day 5 of post-CABG (+/- 1 day, or until day of ICU discharge)
Time on Mechanical Ventilation and Ventilator Free Days
Time on Mechanical Ventilation of participant in hours and Ventilator Free Days in days during ICU stay
Time frame: 3-months post-CABG (+/- 1 month)
30-day readmission and mortality
Incidence of readmission or death within 30 days after CABG
Time frame: 3-months post-CABG (+/- 1 month)
Short Form (36) Health Survey (SF-36)
A survey that determines quality of life. The summary of the health components Physical Health Component (PCS) and Mental Health Component (MCS) are derived from eight subscales PF, RP, BP, GH, VT, SF, RE, MH), where the minimum score represents the worst health and the maximum score represents the best health. The minimum and maximum score of the subscales are as follow: 1. PF (minimum 19.3, maximum 57.5), 2. RP (minimum 21.2, maximum 57.2), 3. BP (minimum 21.7, maximum 62.0), 4. GH (minimum 19.0, maximum 66.5), 5. VT (minimum 22.9, maximum 70.4), 6. SF (minimum 17.2, maximum 57.3), 7. RE (minimum 14.4, maximum 56.2), 8. MH (minimum 11.6, maximum 63.9).
Time frame: 2 weeks prior to operation (Baseline measurement, +/- 2 weeks), 3-months post-CABG (+/- 1 month)
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2024 (actual). Primary completion is estimated for Aug 2026, 31 months after the start.
Of 186 non-industry interventional studies with no phase under Emergence Delirium, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 36. This study's planned 31 months is above that.
Counting every sponsor, half of 186 studies reached it within 19 months; a quarter within 7 and three quarters within 36.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National University Hospital, Singapore →